Biotest: Press and Analyst Conference FY 2015 (Biotest) - Mar 26, 2016 - "BT-062 phase I/IIa study no. 983 in Multiple Myeloma"; "Results of BT-062 with Pomalidomide / Dexamethasone: A total of 17 patients were enrolled; 2 patients were replaced (not evaluable for efficacy), 11/15 = 73% showed a response ( ≥ PR) to treatment, 8 patients are on treatment without progressive disease for more than 8 months"
P1/2 data • Hematological Malignancies • Multiple Myeloma • Oncology
|